The startup develops over-the-counter and prescription products that target various vaginal health conditions, utilizing a lubricant that enhances the cellular properties of the vaginal epithelium through the application of cholesterol and fatty acids. This approach enables clinicians to effectively manage and treat issues related to vaginal health across different life stages.

Avive Solutions develops the Avive Connect AED, an automated external defibrillator that wirelessly transmits real-time incident data to 911 telecommunicators, enhancing first responders' preparedness during Sudden Cardiac Arrest emergencies. This device eliminates the need for battery replacements and automates maintenance tasks, ensuring reliable performance and reducing ownership costs.

Caresyntax provides an AI-powered, vendor-neutral surgical intelligence platform that integrates data from electronic medical records, video, and device metrics to enhance surgical workflow and decision-making. The platform improves patient outcomes, operational efficiency, and profitability by offering real-time support during procedures and comprehensive analytics for pre- and post-operative care.

The startup develops biopharmaceutical technology that utilizes a chromatography-free, modular, and continuous process for monoclonal antibody production and viral vector separation. This approach significantly lowers capital and operating expenditures for biologics manufacturing plants, allowing biopharma companies to dynamically adjust production capacity.

Huma provides a regulated cloud platform for building and deploying AI-first digital health applications, including remote patient monitoring and Software as a Medical Device (SaMD) solutions. The platform accelerates the creation of health super apps and virtual care models, enhancing clinical efficiency and patient outcomes through integrated AI capabilities and global regulatory compliance.

The startup develops analytics software that integrates multi-omic data with AI analytics to enhance drug candidate identification and biomarker discovery. This technology enables precision medicine organizations to streamline research processes and significantly reduce time-to-market for new treatments.